Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non-Current Assets (2016 - 2026)

Pharma-Bio Serv filings provide 16 years of Other Non-Current Assets readings, the most recent being $120783.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 46.45% to $120783.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $120783.0, a 46.45% decrease, with the full-year FY2025 number at $120754.0, down 46.47% from a year prior.
  • Other Non-Current Assets hit $120783.0 in Q1 2026 for Pharma-Bio Serv, roughly flat from $120754.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $353294.0 in Q1 2022 to a low of $111665.0 in Q4 2023.
  • Median Other Non-Current Assets over the past 5 years was $130874.0 (2022), compared with a mean of $174368.5.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 63.14% in 2023 and later soared 102.06% in 2025.
  • Pharma-Bio Serv's Other Non-Current Assets stood at $130874.0 in 2022, then decreased by 14.68% to $111665.0 in 2023, then skyrocketed by 102.03% to $225599.0 in 2024, then crashed by 46.47% to $120754.0 in 2025, then grew by 0.02% to $120783.0 in 2026.
  • The last three reported values for Other Non-Current Assets were $120783.0 (Q1 2026), $120754.0 (Q4 2025), and $225649.0 (Q3 2025) per Business Quant data.